Vectors Research Management, LLC Thermo Fisher Scientific Inc. Transaction History

Vectors Research Management, LLC

$293 Million
Q4 2024

A detailed history of Vectors Research Management, LLC transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Vectors Research Management, LLC holds 7,333 shares of TMO stock, worth $3.94 Million. This represents 1.3% of its overall portfolio holdings.

Number of Shares

7,333

Previous 7,812 6.13%

Holding current value

$3.94 Million

Previous $4.83 Million 20.99%

% of portfolio

1.3%

Previous 1.46%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	SELL	$501.29 - $612.85 $240,117 - $293,555	-479 Reduced 6.13%	7,333 $3.81 Million
Q3 2024 Nov 06, 2024	SELL	$531.86 - $624.21 $65,950 - $77,402	-124 Reduced 1.56%	7,812 $4.83 Million
Q2 2024 Aug 09, 2024	SELL	$541.52 - $599.02 $63,899 - $70,684	-118 Reduced 1.47%	7,936 $4.39 Million
Q1 2024 May 14, 2024	SELL	$528.82 - $599.43 $14.6 Million - $16.5 Million	-27,536 Reduced 77.37%	8,054 $4.68 Million
Q4 2023 Feb 12, 2024	BUY	$431.41 - $532.94 $11.7 Million - $14.4 Million	27,039 Added 316.21%	35,590 $4.06 Million
Q3 2023 Nov 09, 2023	SELL	$498.29 - $574.41 $30,893 - $35,613	-62 Reduced 0.72%	8,551 $4.12 Million
Q2 2023 Aug 08, 2023	SELL	$508.46 - $591.13 $105,251 - $122,363	-207 Reduced 2.35%	8,613 $4.49 Million
Q1 2023 May 04, 2023	SELL	$535.0 - $604.82 $47,615 - $53,828	-89 Reduced 1.0%	8,820 $5.08 Million
Q4 2022 Feb 08, 2023	BUY	$484.71 - $571.37 $194,853 - $229,690	402 Added 4.73%	8,909 $4.91 Million
Q3 2022 Nov 08, 2022	SELL	$507.19 - $604.49 $58,326 - $69,516	-115 Reduced 1.33%	8,507 $4.32 Million
Q2 2022 Aug 12, 2022	SELL	$500.9 - $612.21 $85,153 - $104,075	-170 Reduced 1.93%	8,622 $4.68 Million
Q1 2022 May 16, 2022	SELL	$524.0 - $644.92 $141,480 - $174,128	-270 Reduced 2.98%	8,792 $5.19 Million
Q4 2021 Feb 15, 2022	BUY	$569.0 - $667.24 $30,157 - $35,363	53 Added 0.59%	9,062 $6.05 Million
Q3 2021 Nov 12, 2021	BUY	$509.53 - $609.78 $105,472 - $126,224	207 Added 2.35%	9,009 $5.15 Million
Q2 2021 Aug 09, 2021	BUY	$441.0 - $508.24 $74,970 - $86,400	170 Added 1.97%	8,802 $4.44 Million
Q1 2021 May 18, 2021	BUY	$439.85 - $518.83 $45,744 - $53,958	104 Added 1.22%	8,632 $3.94 Million
Q4 2020 Feb 09, 2021	BUY	$435.06 - $527.66 $60,908 - $73,872	140 Added 1.67%	8,528 $3.97 Million
Q3 2020 Nov 16, 2020	SELL	$359.77 - $441.52 $24,824 - $30,464	-69 Reduced 0.82%	8,388 $3.72 Million
Q2 2020 Aug 13, 2020	BUY	$275.2 - $362.34 $6,054 - $7,971	22 Added 0.26%	8,457 $3.06 Million
Q1 2020 May 14, 2020	BUY	$255.3 - $340.05 $809,811 - $1.08 Million	3,172 Added 60.27%	8,435 $2.39 Million
Q4 2019 Feb 14, 2020	BUY	$271.93 - $328.04 $304,017 - $366,748	1,118 Added 26.97%	5,263 $1.71 Million
Q1 2019 Jul 15, 2019	BUY	$212.17 - $273.72 $848,680 - $1.09 Million	4,000 Added 2758.62%	4,145 $1.14 Million
Q4 2018 Feb 13, 2019	SELL	$208.47 - $251.98 $828,668 - $1 Million	-3,975 Reduced 96.48%	145 $32,000
Q3 2018 Nov 15, 2018	BUY	$205.57 - $244.32 $846,948 - $1.01 Million	4,120 New	4,120 $847,000

Others Institutions Holding TMO

# of Institutions

2,891

Shares Held

342M

Call Options Held

2.09M

Put Options Held

2.73M

View Full List

About THERMO FISHER SCIENTIFIC INC.

Ticker TMO
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 391,788,992
Market Cap $211B
Description
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...

More about TMO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vectors Research Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vectors Research Management, LLC with notifications on news.

Account

Vectors Research Management, LLC Thermo Fisher Scientific Inc. Transaction History